These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 18819693

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital.
    Durrieu G, Batz A, Rousseau V, Bondon-Guitton E, Petiot D, Montastruc JL.
    Eur J Clin Pharmacol; 2014 Dec; 70(12):1519-26. PubMed ID: 25304009
    [Abstract] [Full Text] [Related]

  • 4. [Adverse effects of anticancer drugs: apropos of a pharmacovigilance study at a specialized oncology institution].
    Couffignal AL, Lapeyre-Mestre M, Bonhomme C, Bugat R, Montastruc JL.
    Therapie; 2000 Dec; 55(5):635-41. PubMed ID: 11201979
    [Abstract] [Full Text] [Related]

  • 5. Adverse drug reactions related hospitalization identified by discharge ICD-9 codes in a univeristy hospital in Riyadh.
    Al-Malaq HM, Al-Aqeel SA, Al-Sultan MS.
    Saudi Med J; 2008 Aug; 29(8):1145-50. PubMed ID: 18690308
    [Abstract] [Full Text] [Related]

  • 6. Reporting adverse drug reactions on a geriatric ward: a pilot project.
    Somers A, Petrovic M, Robays H, Bogaert M.
    Eur J Clin Pharmacol; 2003 Feb; 58(10):707-14. PubMed ID: 12610749
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P, Montastruc JL.
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. System for voluntary reporting of adverse drug reactions in a university hospital.
    Vorce-West TE, Barstow L, Butcher B.
    Am J Hosp Pharm; 1989 Nov; 46(11):2300-3. PubMed ID: 2589347
    [Abstract] [Full Text] [Related]

  • 14. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K, Shalviri G, Zarbakhsh A, Daryabari N, Yousefian S.
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [Abstract] [Full Text] [Related]

  • 15. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs.
    Jarernsiripornkul N, Kakaew W, Loalukkana W, Krska J.
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):240-5. PubMed ID: 19148880
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Drug related hospital admissions in subspecialities of internal medicine.
    Hallas J.
    Dan Med Bull; 1996 Apr; 43(2):141-55. PubMed ID: 8741207
    [Abstract] [Full Text] [Related]

  • 19. [Organization and results of drug vigilance in France].
    Bégaud B, Chaslerie A, Haramburu F.
    Rev Epidemiol Sante Publique; 1994 Apr; 42(5):416-23. PubMed ID: 7973001
    [Abstract] [Full Text] [Related]

  • 20. Anti-infectives-induced adverse drug reactions in hospitalized patients.
    Gholami K, Parsa S, Shalviri G, Sharifzadeh M, Assasi N.
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):501-6. PubMed ID: 15844215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.